[go: up one dir, main page]

MA39300A1 - Anti-IL-13 / IL-17 Bispecific Antibodies and Their Uses - Google Patents

Anti-IL-13 / IL-17 Bispecific Antibodies and Their Uses

Info

Publication number
MA39300A1
MA39300A1 MA39300A MA39300A MA39300A1 MA 39300 A1 MA39300 A1 MA 39300A1 MA 39300 A MA39300 A MA 39300A MA 39300 A MA39300 A MA 39300A MA 39300 A1 MA39300 A1 MA 39300A1
Authority
MA
Morocco
Prior art keywords
bispecific antibodies
methods
antibodies
asthma
moderate
Prior art date
Application number
MA39300A
Other languages
French (fr)
Other versions
MA39300B1 (en
Inventor
Christoph Spiess
Lawren Wu
Joseph R Arron
Michael Dillon
David F Choy
Sue Sohn
Whitney Shatz
Original Assignee
Genentech Inc
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Hoffmann La Roche filed Critical Genentech Inc
Priority claimed from PCT/US2015/017168 external-priority patent/WO2015127405A2/en
Publication of MA39300A1 publication Critical patent/MA39300A1/en
Publication of MA39300B1 publication Critical patent/MA39300B1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des anticorps bispécifiques anti-il-13/il-17, en particulier des anticorps anti-il-13, il-17/aa, af et ff anticorps et des méthodes d'utilisation de ceux-ci, y compris, sans limitation, des méthodes d'utilisation des anticorps bispécifiques anti-il-13/il-17 pour le traitement de l'asthme modéré à grave et/ou de l'asthme éosinophilique.The invention relates to anti-IL-13 / IL-17 bispecific antibodies, particularly anti-IL-13, IL-17 / aa, AF and FF antibodies and methods of use thereof, including , without limitation, methods of using anti-il-13 / il-17 bispecific antibodies for the treatment of moderate to severe asthma and / or eosinophilic asthma.

MA39300A 2014-02-21 2015-02-23 Anti-IL-13 / IL-17 Bispecific Antibodies and Their Uses MA39300B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461942823P 2014-02-21 2014-02-21
PCT/US2015/017168 WO2015127405A2 (en) 2014-02-21 2015-02-23 Anti-il-13/il-17 bispecific antibodies and uses thereof

Publications (2)

Publication Number Publication Date
MA39300A1 true MA39300A1 (en) 2018-08-31
MA39300B1 MA39300B1 (en) 2019-04-30

Family

ID=58699632

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39300A MA39300B1 (en) 2014-02-21 2015-02-23 Anti-IL-13 / IL-17 Bispecific Antibodies and Their Uses

Country Status (2)

Country Link
AR (1) AR099519A1 (en)
MA (1) MA39300B1 (en)

Also Published As

Publication number Publication date
MA39300B1 (en) 2019-04-30
AR099519A1 (en) 2016-07-27

Similar Documents

Publication Publication Date Title
MA41013B1 (en) Compositions comprising bacterial strains
MA43982A (en) ANTI-TNF ANTIBODIES, COMPOSITIONS, METHODS AND USE FOR THE TREATMENT OR PREVENTION OF TYPE 1 DIABETES
MA40682A (en) ANTI-OX40 ANTIBODIES AND CORRESPONDING METHODS OF USE
MA53356A (en) SUBCUTANEOUS FORMULATIONS OF ANTI-CD38 ANTIBODIES AND THEIR USES
EA201891202A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201891201A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201890050A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA201890049A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
MA49726B1 (en) ANTI-CGRP ANTIBODY FORMULATION
MA40576B1 (en) Anti-her2 antibodies and immunoconjugates
EA201891199A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
WO2015153889A3 (en) Materials and methods for the treatment of latent viral infection
EA201890051A1 (en) COMPOSITIONS CONTAINING BACTERIAL STRAINS
EA202092435A2 (en) MONOCLONAL ANTIBODIES AGAINST BCMA
PH12016501547A1 (en) Anti-il-13/il-17 bispecific antibodies and uses thereof
MA47719A (en) ESKETAMINE FOR THE TREATMENT OF DEPRESSION
MA47442A (en) ANTI-TNF ANTIBODIES, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLARTHRITIS
MA40671A1 (en) Anti-c10orf54 Antibodies and Their Uses
MA39248B1 (en) Anti-jagged1 antibodies and methods of use thereof
EA201790984A1 (en) ANTI-CD79B ANTIBODIES AND METHODS OF THEIR APPLICATION
EA201791029A1 (en) ANTIBODIES AGAINST INTERLEUKIN-33 AND THEIR APPLICATION
MA51815A (en) METHODS OF TREATMENT OR PREVENTION OF MIGRAINES WITH ANTIBODIES AGAINST THE CGRP RECEPTOR
MA47362A (en) ANTI-TNF ANTIBODIES, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACTIVE PSORIASIC RHEUMATISM
MA46619B1 (en) Anti-il-33 antibodies and their uses
MA45999A (en) ANTI-PD-1 ANTIBODIES, OR THEIR FRAGMENTS, FOR THE TREATMENT OF HEPATITIS B